SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950123-11-098599
Filing Date
2011-11-14
Accepted
2011-11-14 17:04:20
Documents
2
Group Members
PILLAR INVEST CORPPILLAR PHARMACEUTICALS I LPYOUSSEF EL ZEIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D c24640sc13d.htm SC 13D 97633
2 EXHIBIT 1 c24640exv99w1.htm EX-99.1 4075
  Complete submission text file 0000950123-11-098599.txt   103485
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Subject) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-50211 | Film No.: 111204092
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PILLAR INVEST OFFSHORE SAL STARCO CENTER BLOC B FL3, OMAR DAOUK ST BEIRUT M8 2020-3313
Business Address C/O PILLAR INVEST OFFSHORE SAL STARCO CENTER BLOC B FL3, OMAR DAOUK ST BEIRUT M8 2020-3313 0119611363362
Pillar Pharmaceuticals I LP (Filed by) CIK: 0001534425 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D